rhEndostatin Protein Involving Pediatric Patients With Cancer

NCT00165373 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Lack of drug supply

Conditions

Solid Tumors

Interventions

DRUG: rhEndostatin

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]